Literature DB >> 31283913

Preconditioning with hydrogen sulfide ameliorates cerebral ischemia/reperfusion injury in a mouse model of transient middle cerebral artery occlusion.

Lei Tao1, Qian Yu1, Pin Zhao2, Qian Yang2, Binrong Wang1, Yonghui Yang1, Jianke Kuai3, Qian Ding4.   

Abstract

Ischemic stroke and reperfusion injury are a common and serve medical situation in the elderly population. H2S is a gas neuromodulator which also possesses anti-oxidant and anti-inflammatory properties, and is found to play neuroprotective effect in neurodegenerative diseases. This study investigated the effect of endogenous and exogenous H2S in a mouse model of ischemic stroke. 129P2-Cbstm1Unc/J mice with heterozygous mutants in H2S generating enzyme cystathionine β-synthase were used to study the effect of endogenous H2S. H2S donor NaHS was used as exogenous H2S. Animals were pretreated with H2S and then subjected to middle cerebral artery occlusion surgery. Behavioral outcome was evaluated by novel object recognition test. Inflammatory cytokines were measured using ELISA. Western blot was used to detect the activation of NF-κB. Aged 129P2-Cbstm1Unc/J mice showed exaggerated inflammation and more severe cognitive impairment after ischemia, while exogenous H2S treatment inhibited inflammation and attenuated behavioral impairment. The anti-inflammatory effect of H2S was mediated by inhibiting NF-κB. Our findings suggest that both endogenous and exogenous H2S are involved in the neuroprotection against ischemia/reperfusion-induced cerebral injury.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystathionine β-synthase; Inflammation; Ischemia/reperfusion injury; NaHS

Mesh:

Substances:

Year:  2019        PMID: 31283913     DOI: 10.1016/j.cbi.2019.108738

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Hydrogen Sulfide and the Immune System.

Authors:  Peter Rose; Yi-Zhun Zhu; Philip K Moore
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Sulfide catabolism ameliorates hypoxic brain injury.

Authors:  Eizo Marutani; Masanobu Morita; Shuichi Hirai; Shinichi Kai; Robert M H Grange; Yusuke Miyazaki; Fumiaki Nagashima; Lisa Traeger; Aurora Magliocca; Tomoaki Ida; Tetsuro Matsunaga; Daniel R Flicker; Benjamin Corman; Naohiro Mori; Yumiko Yamazaki; Annabelle Batten; Rebecca Li; Tomohiro Tanaka; Takamitsu Ikeda; Akito Nakagawa; Dmitriy N Atochin; Hideshi Ihara; Benjamin A Olenchock; Xinggui Shen; Motohiro Nishida; Kenjiro Hanaoka; Christopher G Kevil; Ming Xian; Donald B Bloch; Takaaki Akaike; Allyson G Hindle; Hozumi Motohashi; Fumito Ichinose
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

Review 3.  Protective Effect of Hydrogen Sulfide on Cerebral Ischemia-Reperfusion Injury.

Authors:  Masood Muqadas; Salah Adlat; Gang Deng; Haiyun Zheng; Ge Li; Ping Zhu; M I Nasser
Journal:  Cell Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.046

4.  The Protective Effects of Hydrogen Sulfide New Donor Methyl S-(4-Fluorobenzyl)-N-(3,4,5-Trimethoxybenzoyl)-l-Cysteinate on the Ischemic Stroke.

Authors:  Jing Fan; Junxi Du; Zhongwei Zhang; Wenjing Shi; Binyan Hu; Jiaqin Hu; Yan Xue; Haipeng Li; Wenjin Ji; Jian Zhuang; Pengcheng Lv; Kui Cheng; Kun Chen
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.411

Review 5.  Therapeutic applications of hydrogen sulfide and novel donors for cerebral ischemic stroke: a narrative review.

Authors:  Jia-Sheng Ding; Yan Zhang; Tian-Yi Wang; Xiang Li; Cheng Ma; Zhong-Mou Xu; Qing Sun; Xiang Xu; Gang Chen
Journal:  Med Gas Res       Date:  2023 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.